Back to News
Market Impact: 0.35

Vertical Aerospace activates battery production line in UK

EVTLHONAALVTOLSMCIAPP
Technology & InnovationTransportation & LogisticsCompany FundamentalsCorporate Guidance & OutlookAnalyst InsightsBanking & LiquidityProduct LaunchesRenewable Energy Transition
Vertical Aerospace activates battery production line in UK

Vertical Aerospace brought an automated battery pilot production line online at its 15,000 sq ft Vertical Energy Centre; batteries delivered up to 1.4 MW peak in testing and the company targets certification in 2028. The company is valued at $386M, shares are down 26% YTD to $3.92, and levered free cash flow was negative $97.86M LTM; Raymond James downgraded the stock, warning liquidity may last to mid‑June excluding roughly $92M of ATM capacity. Operational momentum (≈1,500 pre-orders, a planned 30,000 sq ft second facility to triple capacity, and £6.4M planned investment by 2027) supports long-term commercialisation, but near-term liquidity and the analyst downgrade raise execution risk.

Analysis

Verticalizing battery assembly materially changes the profit pool from a one-time airframe sale toward recurring aftermarket and service cashflows; every manufactured pack is simultaneously a potential spare, warranty exposure and long-duration revenue stream. That creates a two-way lever: if cell costs fall or vertical scales, gross margins on replacement packs could be 200–400bp higher than selling whole aircraft services, but warranty replacements and thermal events introduce concentrated tail liabilities that can wipe out early margins in a capital-constrained firm. Supply-chain friction is the single biggest operational cadence risk. Limited access to high-density cells, long lead times for automated tooling and a tight pool of qualified thermal-management suppliers create bottlenecks that will determine the pace of commercial availability — not the headline production-line switch. This favors deep-pocketed component suppliers and tier-1 integrators with dual-sourcing and scale economics, and disfavors small OEMs that cannot pre-buy cell capacity. The funding and certification pathways make this a binary multi-year trade, not a near-term momentum play. Key catalysts that will reprice equity are (1) secured multi-year cell/pack supply agreements, (2) demonstrable outside-the-factory reliability data reducing warranty provisioning, and (3) conversion of conditional orders into firm revenue — any one of which can produce >2x equity moves, while the absence of progress or adverse test incidents can amplify downside quickly.